e-learning
resources
Munich 2006
Sunday 03.09.2006
Screening, diagnosis, staging, prognosis, biological features
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluating the role of muc4 expression in the differential diagnosis of mesothelioma and adenocarcinoma of the lung
A. Kargi, A. Hayretdag, Z. Aydogdu, D. Gurel, A. Onen, A. Sanli, A. Akkoclu (Izmir, Turkey)
Source:
Annual Congress 2006 - Screening, diagnosis, staging, prognosis, biological features
Session:
Screening, diagnosis, staging, prognosis, biological features
Session type:
E-Posters in free access
Number:
562
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kargi, A. Hayretdag, Z. Aydogdu, D. Gurel, A. Onen, A. Sanli, A. Akkoclu (Izmir, Turkey). Evaluating the role of muc4 expression in the differential diagnosis of mesothelioma and adenocarcinoma of the lung. Eur Respir J 2006; 28: Suppl. 50, 562
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
The clinical effect and expression of alpha-methylacyl-CoA racemace (AMACR) in the differential diagnosis of malign mesothelioma and adenocarcinoma of lung
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
The role of TTF-1 in differentiation of primary and metastatic adenocarcinomas of the lung
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005
The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
COX-2 expression during early lung squamous cell carcinomas oncogenesis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005
Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Prognostic significance of MUC1 expression in resected lung adenocarcinoma
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
p53 and mdm2 expression in nonsmall cell lung cancer (NSCLC): the lack of prognostic relevance
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001
The role of radiology in lung adenocarcinoma classification
Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update
Year: 2009
Differential cytokine expression in non-small cell lung carcinomas
Source: Eur Respir J 2007; 30: Suppl. 51, 512s
Year: 2007
CXCL12 expression in malignant mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007
Evaluation of the role of bronchoscopy in the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006
BAP1 expression and treatment outcomes in malignant mesothelioma.
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017
Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006
Clinical significance and functional roles of FoxM1 in non-small cell lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Expression of miR-126 and miR-126* in primary tumors and metastasis of adenocarcinoma and squamous carcinoma of the lung
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
The role of molecular pathology in diagnosis and treatment of lung cancer
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007
Distribution of BCL-2 gene expression and its prognostic value in non-small cell pulmonary cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept